Breaking News: In a major breakthrough, Elon Musk’s brain chip company has announced that it has obtained approval from the US Food and Drug Administration (FDA) to commence its inaugural human testing phase. The clearance granted by the FDA allows the brain-machine interface firm to proceed with its first clinical study involving human participants. This milestone approval marks a pivotal advancement for Neuralink’s pioneering technology. This Brain Chip approval for human trials was revealed to the public through a tweet posted by Neuralink which was subsequently shared by Elon Musk.
Know About Neuralink
Elon Musk, along with a team of seven scientists and engineers, established Neuralink in 2016. This initial group of hires brought together expertise in diverse fields such as neuroscience, biochemistry, and robotics. In January 2017, the trademark “Neuralink” was acquired from its previous owners.
During April 2017, Neuralink made an announcement outlining its mission to develop devices for the treatment of severe brain diseases in the near term, while ultimately aspiring to achieve human enhancement, often referred to as transhumanism. Elon Musk’s interest in this trending technology was partly inspired by the science fiction notion of a “neural lace” featured in The Culture, a series of ten novels authored by Iain M. Banks.
Microsoft And Android Integration: How The Alliance Could Challenge Apple
How Does Neuralink’s Brain Chip Technology Work?
Neuralink has developed a computer chip embedded with electrodes, intended to be surgically implanted onto the brain’s surface using a robotic device. Elon Musk envisions a future where these devices can be regularly upgraded.
Neuralink aims to leverage its microchips to address conditions like paralysis and blindness, as well as assist individuals with disabilities in utilizing computers and mobile technology. Through extensive testing on monkeys, the chips have been developed to decode brain signals and transmit information to external devices via Bluetooth connectivity. This innovative technology holds the potential to significantly improve the lives of those with neurological challenges and empower them to interact with the digital world.
Elon Musk’s Brain Chip Approval Tweet
Neuralink in its tweet on 26th May, 2023, excitedly announced that they have received the FDA’s approval. They can launch their first-in-human clinical study anytime soon. They also expressed that this happened as a result of the incredible work done by the Neuralink team in close collaboration with FDA. They said that this is an important first step that will allow their technology to help many people.
Congratulations Neuralink team! https://t.co/AWZGf33UDr— Elon Musk (@elonmusk) May 26, 2023
They ended their tweet by revealing that the recruitment for their clinical trial is not yet open and that they will soon announce more information regarding this.
In reply to this, Elon Musk retweeted Neuralink’s Tweet congratulating the Neuralink team.
After this Elon Musk’s brain chip approval tweet, Twitter was flooded with huge reactions of people. Everyone expressed their opinions on the topic and this news was spread all around rapidly.
Throughout the years, Elon Musk has consistently shared his ambitious vision for Neuralink. His statements have attracted considerable attention, particularly when he expressed confidence in the device’s safety to the extent that he would be open to implanting them in his own children.
The brain chip human trail will bring in a lot more clarity regarding its technology. This trending technology by Elon Musk’s Neuralink might turn out to be a game changer for the healthcare sector in all the good ways. More updates regarding this Brain Chip and regarding when the brain chip human trial will start will be out soon. Everyone sure is excited to see some real results as Neuralink has set the expectations very high.
To stay updated with more information on Elon Musk’s Brain Chip, stay tuned to Vasai Virar News. Also, get updates on daily local news, entertainment news, education, technology and top 10.